Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|April 8, 2019
Reduced VMAT2 expression exacerbates the hyposmia in the MPTP model of Parkinson's diseaseKai Ma, Chao Han, Guoxin Zhang, et al.
Cell Death & Disease|February 22, 2019
Microglia as modulators of exosomal alpha-synuclein transmissionYun Xia, Guoxin Zhang, Chao Han, et al.
CNS Neuroscience & Therapeutics|May 4, 2024
Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1Yunna Li, Yiming Wang, Liang Kou, et al.
Molecular Neurobiology|January 5, 2022
Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease?Sijia Yin, Chao Han, Yun Xia, et al.
Frontiers in Neurology|April 6, 2019
Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP+ and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling PathwayXingfang Guo, Chao Han, Kai Ma, et al.
The Science of the Total Environment|May 23, 2022
The pyrethroids metabolite 3-phenoxybenzoic acid induces dopaminergic degenerationFang Wan, Ting Yu, Junjie Hu, et al.
The Science of the Total Environment|March 19, 2021
Anthropogenic emissions of atomic chlorine precursors in the Yangtze River Delta region, ChinaXin Yi, Sijia Yin, Ling Huang, et al.
Frontiers in Neurology|August 27, 2019
Immune Reconstitution Inflammatory Syndrome Secondary to Autoimmune Hemolytic Anemia and Cryptococcal MeningitisSiJia Yin, Yan Xu, Jinsha Huang, et al.
CNS Neuroscience & Therapeutics|September 1, 2022
Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysisQiulu Zhou, Chao Han, Yun Xia, et al.
Neurobiology of Disease|July 11, 2023
Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's diseaseYiming Wang, Yun Xia, Liang Kou, et al.
Pageof 3